For many women, turning 35 marks a subtle but undeniable shift. The same nutrition plan that once worked effortlessly now feels ineffective. Exercise requires more recovery time. Sleep disturbances appear unexpectedly. Weight gain, particularly around the abdomen, becomes more persistent. These changes are not imagined, and they are not a reflection of diminished willpower. … [Read more...] about Medical Weight Loss for Women Over 35: A Hormonal and Metabolic Perspective
GLP-1 & Medical Weight Loss
GLP-1 (glucagon-like peptide-1) is a naturally occurring hormone that plays a key role in appetite regulation, blood sugar control, and metabolism. In recent years, GLP-1–based medications have transformed how conditions such as obesity, insulin resistance, and type 2 diabetes are treated.
In this section of The Healthy Bunny, you’ll find in-depth, easy-to-understand information about GLP-1 and metabolic health. We explain what GLP-1 is, how it works in the body, and how medications like Ozempic, Wegovy, and Mounjaro support sustainable weight loss and improved metabolic function.
You’ll also find practical guidance on benefits and risks, side effects and how to manage them, and how GLP-1 therapy fits into a broader health approach that includes nutrition, movement, lifestyle habits, and medical care. For those managing type 2 diabetes or insulin resistance, we explore how GLP-1 affects blood sugar, insulin sensitivity, and long-term health outcomes.
This content is designed to support informed decision-making and meaningful conversations with healthcare providers. Whether you’re just learning about GLP-1, considering medication, or already using it, this section provides clear, evidence-informed education — without fear-based messaging or unrealistic expectations.
The Transition Phase: Moving from Weight Loss to Medical Stability
Weight loss is often portrayed as the finish line. The number on the scale drops, clothes fit differently, laboratory values improve, and confidence rises. Yet biologically, weight loss is not the end of the story. It is a powerful physiological disruption. The real milestone is not simply achieving a lower weight, but stabilising the body in its new metabolic state. This … [Read more...] about The Transition Phase: Moving from Weight Loss to Medical Stability
Alcohol and GLP-1 Medications: What You Should Know
GLP-1 receptor agonists have reshaped the landscape of weight management and metabolic care. Medications such as Wegovy and Mounjaro are increasingly used not only for weight reduction but also for improving insulin sensitivity, stabilising blood glucose, and reducing cardiometabolic risk. As their use becomes more widespread, a common and important question arises: what … [Read more...] about Alcohol and GLP-1 Medications: What You Should Know
Is It Safe to Stay on GLP-1 Injections Long Term for Weight Loss?
The question of whether long-term medication use for weight loss is safe has become increasingly relevant as GLP-1 receptor agonists move from diabetes treatment into mainstream obesity care. Medications such as Wegovy and Mounjaro are now widely prescribed for chronic weight management, and many people using them are asking an important follow-up question: how long should I … [Read more...] about Is It Safe to Stay on GLP-1 Injections Long Term for Weight Loss?
GLP-1 Weight Loss Providers in the UK: A Safe, Evidence-Based Comparison
GLP-1 medications such as Ozempic (semaglutide) and Mounjaro (tirzepatide) are increasingly prescribed in the UK to support weight loss and metabolic health. As demand grows, more private providers are offering access online — making it essential for patients to understand how these services differ in safety, oversight, and long-term support. This guide compares leading UK … [Read more...] about GLP-1 Weight Loss Providers in the UK: A Safe, Evidence-Based Comparison